(Q36454562)

14 August 2017

title

Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease (English)

1 reference

14 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

6 January 2023

author name string

J. W. van der Velden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

W. L. van Putten

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

V. F. Guinee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

R. Pfeiffer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

F. E. van Leeuwen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

E. A. van der Linden

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

I. Vardomskaya

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

W. Lane

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

M. Durand

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

C. Lagarde

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3403068

6 January 2023

language of work or name

English

0 references

publication date

1 August 1988

1 reference

14 August 2017

15 August 1988

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3403068

full work available at URL

6 January 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910420218

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910420218

6 January 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

International Journal of Cancer

6 January 2023

published in

1 reference

14 August 2017

volume

42

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

252-255

1 reference

Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agent

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910420218

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Risk of leukemia in patients treated for Hodgkin's disease

6 January 2023

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Secondary malignancy after treatment of Hodgkin's disease: an evolving picture

6 January 2023

6

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

6 January 2023

7

1

Coleman

1982

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Hematologic neoplasia in patients treated for Hodgkin's disease

6 January 2023

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

6 January 2023

Cancer Treatment Reports

9

66

1023

Coltman

1982

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

A method for analysing case-control studies with ordinal exposure variables

6 January 2023

10

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

6 January 2023

Cancer Treatment Reports

11

66

1035

Glicksman

1982

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma

6 January 2023

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Acute myeloid leukemia following treatment of Hodgkin's disease: a review

6 January 2023

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Acute leukaemia in patients treated for Hodgkin's disease.

6 January 2023

16

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease

6 January 2023

18

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy.

6 January 2023

19

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Acute leukemia in Hodgkin's disease.

6 January 2023

20

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience

6 January 2023

22

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Risk of second cancers after treatment for Hodgkin's disease

6 January 2023

23

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Second acute leukemia and other malignancies following treatment for Hodgkin's disease

6 January 2023

24

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

Splenectomy in Hodgkin's disease and second leukaemias.

6 January 2023

25

1 reference

https://api.crossref.org/works/10.1002/IJC.2910420218

6 January 2023

Identifiers

1 reference

14 August 2017

1 reference